Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms.

Kleppe, Maria; Koche, Richard; Zou, Lihua; van Galen, Peter; Hill, Corinne E; Dong, Lauren; De Groote, Sofie; Papalexi, Efthymia; Hanasoge Somasundara, Amritha V; Cordner, Keith; Keller, Matthew; Farnoud, Noushin; Medina, Juan; McGovern, Erin; Reyes, Jaime; Roberts, Justin; Witkin, Matthew; Rapaport, Franck; Teruya-Feldstein, Julie; Qi, Jun; Rampal, Raajit; Bernstein, Bradley E; Bradner, James E; Levine, Ross L.
Cancer Cell; 33(1): 29-43.e7, 2018 01 08.
Artigo em Inglês | MEDLINE | ID: mdl-29249691